Advanced filters
News
Muscular Dystrophy UK and SMA UK were extremely disappointed to learn earlier this week that,…
News
Recent advances in SMA research have led to the exciting development of genetic therapies, such as…
News
We are pleased to announce that the 2017 Spinal Muscular Atrophy (SMA) best practice care guide for…
News
NICE widens scope of its appraisal of Zolgensma
This will now be in line with the European…
News
In our first condition-specific seminar, which marked SMA Awareness Month, Professor Laurent…
News
On Monday 17 August, Roche announced that the European Medicines Agency (EMA) has validated the…
News
The treatment, which could be the third for the condition, alongside Spinraza and Zolgensma, will…
News
People with SMA Type 1 and 2 may be able to take the oral drug if Spinraza, the first treatment for…
News
The first document, which answers questions about Spinraza and how it works, can be found here.…
News
Patients who are eligible under the terms set out in the Managed Access Agreement will be able to…